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BACKGROUND/PURPOSE: Healthcare-associated infections in neonatal intensive care units (NICUs) 
are associated with a significant risk of morbidity and mortality. Knowledge regarding pathogens, pri-
mary sources of infection and antibiotic resistance in the NICU is essential for developing management 
strategies. This study aimed to analyze the long-term characteristics of healthcare-associated infections in 
a tertiary referral center in southern Taiwan.
METHODS: Infants < 30 days old, with positive blood, cerebrospinal fluid, urine or tissue fluid cultures 
during hospitalization in the NICU of National Cheng Kung University Hospital from July 1989 to June 
2008 were included in the study.
RESULTS: In total, 1,417 organisms and episodes were identified during the study period. Gram-positive 
organisms, Gram-negative organisms and fungi constituted 923 (65.1%), 358 (25.3%) and 136 (9.6%) of 
the pathogens, respectively. Of the Gram-positive organisms, coagulase-negative staphylococci (51.5%), 
Staphylococcus aureus (34.8%) and Enterococcus spp. (6.1%) were the major pathogens; and 27% of Staphylococcus 
aureus isolates were oxacillin-resistant. For the Gram-negative organisms, Klebsiella pneumoniae (22%), 
Pseudomonas aeruginosa (21.8%), Escherichia coli (16.7%) and Enterobacter cloacae (16.7%) were dominant. Also, 
Candida albicans accounted for 50% of fungal infections. The most common source of infection was blood-
stream infection (59.0%), and 5.6% of these were catheter-related. Skin and soft tissue infections were also 
frequent (26.3%).
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Introduction
Nosocomial infections are associated with increased mor-
bidity and mortality, prolonged hospitalization and in-
creased healthcare costs.1 It is estimated that there are 
more than 2,000,000 nosocomial infections in children 
and adults annually in the United States, resulting in 
extended lengths of hospital stay and treatment, and 
adding $17–29 billion to health care costs each year.1–3 
Among the causative pathogens, coagulase-negative sta-
phylococci (CoNS), Staphylococcus aureus, Enterococcus spp., 
Candida spp. and Enterobacter spp. were the most fre-
quently reported by the National Nosocomial Infection 
Surveillance System of the United States.4 This surveil-
lance system also provides evidence that the epidemiology 
of healthcare-associated infections in children differs 
from that in adults with regard to distribution by body 
sites and the pathogens involved.5,6 Unlike other wards in 
the hospital, healthcare-associated infections in the neo-
natal intensive care units (NICUs) are unique in many 
aspects. The microbial causes of neonatal infection are 
age-dependent and unit-dependent, and the species dis-
tribution of the predominant nosocomial pathogens in 
a NICU depends on factors such as endemic microbial 
flora, clinical techniques and antibiotic stewardship poli-
cies.7 Also, neonatal infections are still a challenge to 
the pediatrician, as clinical manifestations of the same 
pathogen can be quite different in different age groups. 
Bloodstream and skin/soft tissue infections caused by 
commensal species play important roles in nosocomial 
infections in the NICU, which poses difficulties in deter-
mining true pathogens from contaminants.8 The distri-
bution and antimicrobial susceptibility of pathogens 
causing healthcare-associated infections, namely their 
characteristics, vary considerably in different regions, over 
time and between hospitals. The availability of timely and 
accurate epidemiological information on healthcare-
associated pathogens is essential for infection control 
and the appropriate selection of empiric antibiotics.9 
Previous studies in Taiwan also support the importance 
of nosocomial infection surveillance in managing the 
issue.10–12
In this study, we aimed to analyze the long-term char-
acteristics of healthcare-associated infections, including 
the clinical features, pathogen distribution, antimicrobial 
susceptibility and yearly changes in a tertiary referring 
center in southern Taiwan.
Methods
Patients and setting
Infants < 30 days old, with positive blood, cerebrospinal 
fluid, urine or tissue fluid cultures during hospitalization 
at the NICU in National Cheng Kung University Hospital 
from July 1989 to June 2008 were enrolled. National 
Cheng Kung University Hospital is a teaching hospital 
that provides tertiary care in southern Taiwan and has a 
16-bed level-III NICU. This NICU offers care to critically 
ill newborns, extremely-low-birthweight premature infants, 
neonates requiring pre- or postoperative management, 
and those who have congenital anomalies that require 
close observation or intervention. The antimicrobial hand 
washing solutions used are 4% chlorhexidine (Hibiscrub) 
and 70% alcohol. Visitors are restricted to two per bed and 
required to wash their hands and wear masks. Universal 
fluconazole prophylaxis for extremely-low-birthweight 
infants started in May 2002.13 Bacterial cultures are ob-
tained routinely from patients with poor activity, respira-
tory symptoms (apnea, bradycardia, cyanosis, hypoxemia, 
and respiratory distress), gastro intestinal symptoms (feeding 
CONCLUSION: Bloodstream and skin/soft tissue infections caused by commensal species play an 
important role in healthcare-associated infections in the NICU. New measures should be developed in 
response to the changing patterns in the NICU.
KEYWORDS: bloodstream infection, Candida albicans, healthcare-associated infection, neonatal intensive 
care units, Staphylococcus aureus
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intolerance, abdominal distention), fever (≥ 38°C) or hy-
pothermia (≤ 35°C). At least one blood sample for culture 
is obtained whenever infection is suspected, and before 
empirical antibiotic treatment (ampicillin/sulbactam and 
amikacin) is started. 
Definitions and microbiological analysis
A healthcare-associated infection is defined as an infec-
tion not present or incubating at the time of NICU admis-
sion.14 Bloodstream infection must meet at least one of 
the following criteria: (1) the patient has a recognized 
pathogen cultured from one or more blood cultures and 
the organism cultured is not related to an infection at 
another site; or (2) the patient has at least one of the fol-
lowing signs or symptoms: fever, hypothermia, apnea or 
bradycardia, and the symptoms/signs are not related to 
an infection at another site. Common skin contaminants 
such as diphtheroids (Corynebacterium spp.), Bacillus (not 
B. anthracis) spp., Propionibacterium spp., CoNS (including 
S. epidermidis), viridans group Streptococci, Aerococcus spp., 
and Micrococcus spp. are considered pathogens if positive 
from two or more blood cultures drawn on separate occa-
sions. All blood cultures are processed by the clinical 
microbiology laboratory using the Bactec 9240 system 
(Becton, Dickson and Company, NJ, USA). Skin/soft tissue 
infections must meet at least one of the following criteria: 
(1) the patient has purulent drainage, pustules, vesicles, or 
boils; or (2) the patient has at least two of the following 
signs or symptoms with no other recognized cause: pain 
or tenderness, localized swelling, redness or heat, and at 
least one of the following: (i) organisms cultured from as-
pirate or drainage from affected site, and if organisms are 
normal skin flora [i.e. diphtheroids (Corynebacterium 
spp.), Bacillus (not B. anthracis) spp., Propionibacterium spp., 
CoNS (including S. epidermidis), viridans group Streptococci, 
Aerococcus spp., or Micrococcus spp.], they must be a pure 
culture; (ii) organisms cultured from blood. Antimicrobial 
susceptibility testing is determined using the disk diffu-
sion technique, in accordance with the criteria established 
by the Clinical and Laboratory Standards Institute.15 A 
nosocomial infection surveillance system has been main-
tained by the Center for Infection Control of the hospital 
since 1989. The incidence density of healthcare-associated 
infections was calculated as the number of episodes di-
vided by the number of patient-days at risk.
Statistical analysis
The significance of differences in proportions was deter-
mined by a two-tailed χ2 test, and a p value < 0.05 was con-
sidered to be statistically significant. All the calculations 
were performed using SPSS version 15 (SPSS Inc., Chicago, 
IL, USA).
Results
Characteristics of healthcare-associated infections
In total, 1,417 isolates were identified from July 1989 to 
June 2008. The annual average NICU stay was 6,333 
patient-days, ranging from 9,255 patient-days in 1995 to 
4,696 in 2004. The average infection density was 9.4 per 
1,000 patient-days. The infection densities were lowest in 
2008 (3.9 per 1,000 patient-days) and highest in 1995 
(17.3 per 1,000 patient-days). The most common source 
of infection was bloodstream infection (59.0%) and 5.6% 
of these were catheter-related. The average incidence of 
healthcare-associated bloodstream infection was 5.4, rang-
ing from 1.5 (1989) to 9.4 (1995) per 1,000 patient-days 
(Figure 1). Furthermore, skin and soft tissue infections 
were also frequent (26.3%). Pneumonia accounted for 
4.1% of the healthcare-associated infections (Table 1). 
Gram-positive organisms, Gram-negative organisms 
and fungi constituted 923 (65.1%), 358 (25.3%) and 136 
(9.6%) of the pathogens, respectively. Of the Gram-
positive organisms, CoNS (57.1%), S. aureus (34.8%) and 
Enterococcus spp. (6.1%) were the major pathogens. As for 
the Gram-negative organisms, Klebsiella pneumoniae (22.1%), 
Pseudomonas aeruginosa (21.8%), Escherichia coli (16.8%) and 
Enterobacter cloacae (16.8%) dominated. Candida albicans 
accounted for 52.9% of the fungal infections (Table 2).
Changing patterns of pathogens
For comparison, the study was divided into two periods: 
1989–1998 and 1999–2008. The dominant pathogens re-
sponsible for healthcare-associated infections changed 
over the years. Gram-positive bacteria were still the lead-
ing causes of infection, but S. aureus took the place of 
CoNS during 1999–2008. Enterococcus spp. infections in-
creased compared with the period 1989–1998 (p = 0.02). 
The proportion of Gram-negative pathogens decreased 
from 28.3% in 1989–1998 to 21.3% in 1999–2008 (p < 0.01). 
The percentage of P. aeruginosa and E. cloacae decreased 
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(p < 0.01), while K. pneumoniae (p = 0.38) and E. coli (p = 0.53) 
remained unchanged. A. baumannii was the only Gram-
negative pathogen to increase from 1999–2008 (Table 2).
Fungal infections increased during 1999–2008 and 
Candida spp. accounted for 86.3% (63/73) of these. Except 
for C. albicans (58.7%, 37/63 of candidal infections), infec-
tions caused by non-albicans Candida spp. mainly emerged 
after 2000 (Table 2 and Figure 2). The non-albicans species 
seen in 1999–2008 were C. parapsilosis (57.7%), C. tropicalis 
(23.1%), C. lusitaniae (15.4%) and C. glabrata (3.8%). The aver-
age rate of non-albicans candidal infections increased after 
fluconazole prophylaxis (0.75 vs. 7.93 per 1,000 patient-
days; p = 0.043). However, the average rate of Candida albicans 
infection did not change significantly (5.72 vs. 7.13 per 
1,000 patient-days; p = 0.893).
Trends of antimicrobial susceptibility
To explore the recent trends in antimicrobial resistance 
of the above leading pathogens, the antimicrobial suscep-
tibility patterns of these isolates from 2000–2008 were 
analyzed. The majority (97.4%) of CoNS isolates were re-
sistant to oxacillin, but only 5.7% of isolates were resistant 
to ampicillin/sulbactam. No vancomycin-resistant CoNS 
were detected. Oxacillin-resistance was observed in 91.8% 
of S. aureus isolates; however, all S. aureus remained sensi-
tive to vancomycin and the incidence of oxacillin-resistant 
S. aureus decreased after 2001 (Figure 3). Two thirds of 
the S. aureus isolates were resistant to sulfamethoxazole/
trimethoprim. Only two (6.6%) of the Enterococcus isolates 
were resistant to ampicillin. No vancomycin-resistant 
Enterococcus was found during this period (Table 3).
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Figure 1. Incidence of total healthcare-associated infection and bloodstream infections in neonatal intensive care units from 
1989 to 2008.
Table 1. Characteristics of healthcare-associated infections in 
neonatal intensive care units
Site of infection n (%)
Bloodstream 836 (59.0)
Skin and soft tissue 372 (26.3)
Pneumonia 58 (4.1)
Surgical wound 39 (2.8)
Urinary tract 29 (2.0)
Meningitis 20 (1.4)
Others 63 (4.4)
Total 1,417 (100)
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Table 2. Microorganism distribution of healthcare-associated infections in neonatal intensive care unita
Pathogen 1989–2008 1989–1998 1999–2008 p
Total 1,417 (100) 794 (100) 623 (100)
 Gram-positive organismsb 923 (65.1) 506 (63.7) 417 (66.9) 0.21
  Coagulase-negative staphylococci 527/923 (57.1) 348/506 (68.8) 179/417 (42.9) < 0.01
  Staphylococcus aureus 321/923 (34.8) 117/506 (23.1) 204/417 (48.9) < 0.01
  Enterococcus spp. 56/923 (6.1) 23/506 (4.5) 33/417 (7.9) 0.02
  Others 19/923 (2.1) 18/506 (3.6) 1/417 (0.2) < 0.01
 Gram-negative organismsb 358 (25.3) 225 (28.3) 133 (21.3) < 0.01
  Klebsiella pneumoniae 79/358 (22.1) 48/225 (21.3) 31/133 (23.3) 0.38
  Pseudomonas aeruginosa 78/358 (21.8) 60/225 (26.7) 18/133 (13.5) < 0.01
  Escherichia coli 60/358 (16.8) 36/225 (16.0) 24/133 (18.0) 0.53
  Enterobacter cloacae 60/358 (16.8) 46/225 (20.4) 14/133 (10.5) < 0.01
  Acinetobacter baumanii 38/358 (10.6) 13/225 (5.7) 25/133 (18.8) < 0.01
  Serratia marcescens 9/358 (2.5) 4/225 (1.8) 5/133 (3.8) 0.48
  Others 34/358 (9.5) 18/225 (8.0) 16/133 (12.0) 0.71
 Fungib 136 (9.6) 63 (7.9) 73 (11.7) 0.02
  Candida albicans 72/136 (52.9) 35/63 (55.6) 37/73 (50.7) 0.19
  Non-albicans Candida 26/136 (19.1) 0/63 (0) 26/73 (35.6) < 0.01
  Others 38/136 (27.9) 28/63 (44.4) 10/73 (13.7) 0.02
aData presented as number of positive cases/number of cases in the corresponding subgroup (%); bdata presented as number of positive 
cases/total number of cases.
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Figure 2. Changing pattern of healthcare-associated candidal infections in neonatal intensive care unit, 1990–2007.
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One fifth (5/25) of the K. pneumoniae isolates were 
resistant to third-generation cephalosporins (i.e. ceftri-
axone, cefotaxime), including four (16%, all isolated from 
bloodstream) with extended-spectrum β-lactamases. 
Moreover, most of the E. coli isolates (95.0%) were 
susceptible to third-generation cephalosporins. All the 
P. aeruginosa isolates were susceptible to carbapenems and 
quinolones. More over, 54.5% of the E. cloacae isolates 
showed resistance to gentamicin, but were less resistant 
(22.7%) to amikacin, both common empiric regimens in the 
NICU. Eighty percent of isolated A. baumannii were suscep-
tible to ampicillin/sulbactam, whereas two carbapenem-
resistant A. baumannii (20.0%) isolates were identified 
(Table 3).
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Figure 3. Yearly trends of healthcare-associated oxacillin-resistant Staphylococcus aureus infections in neonatal intensive care units from 
2000 to 2008.
Table 3. Selected antimicrobial susceptibility patterns from tested isolates of healthcare-associated infections in NICU, 
2000–2008
Microorganism Antimicrobial Isolates (n) Resistance, n (%)
Coagulase-negative staphylococci Oxacillin 156 152 (97.4)
 Vancomycin  0 (0)
 Ampicillin/sulbactam  9 (5.8)
Staphylococcus aureus  Oxacillin  97 89 (91.8)
 Vancomycin  0 (0)
 Sulfamethoxazole/trimethoprim  67 (69.1)
Enterococcus sp. Ampicillin  30 2 (6.7)
 Vancomycin  0 (0)
Klebsiella pneumoniae Third-generation cephalosporins  25 5 (20.0)a
Pseudomonas aeruginosa Carbapenems  15 0 (0)
 Ceftazidime  1 (6.7)
 Quinolones  0 (0)
Escherichia coli Third-generation cephalosporins  20 1 (5.0)
Enterobacter cloacae Gentamicin  22 12 (54.5)
 Amikacin  5 (22.7)
Acinetobacter baumanii Carbapenems  10 2 (20.0)
 Ampicillin/sulbactam  2 (20.0)
aIncluding four with extended-spectrum β lactamases.
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Discussion
Neonatal infections are an important cause of mortality 
and morbidity worldwide. In the World Health Organiza-
tion 2000–2003 report, neonatal sepsis and pneumonia 
were responsible for about 1.6 million deaths each year, 
mainly in resource-poor countries.16 However, most of these 
serious neonatal infections in Taiwan and developed coun-
tries occurred in hospitals, and especially in the NICU. 
Knowledge regarding the distribution of infection and 
pathogens is crucial due to the advances in medical tech-
nologies and subsequently longer hospital stays.
The infection densities in the NICU changed over 
time. The first peak was around 1995 and might reflect 
increased hospitalization after the commencement of 
national health insurance. Similar findings were reported 
in a previous study in Taiwan.17 In 2002, our institute 
instigated a strict hand-hygiene policy and standard oper-
ating procedures for placing central venous catheters; 
these might be the reasons for the decrease in healthcare-
associated infections other than bloodstream infections, 
from 2002 to 2008.
In the current study, bloodstream infections served as 
the single most important type of infection because of 
their frequency (59%) and potential life-threatening con-
sequences. Most episodes of nosocomial infection in the 
NICU are associated with indwelling vascular catheters.18,19 
Administration of lipids, low birthweight, respiratory dis-
ease, catheter hub colonization, blood sampling from 
central venous catheters and use of H2 blockers are also 
associated with bloodstream infections.20
S. aureus is the most common pathogen causing pus-
tulosis and cellulitis in neonates. The presence of viru-
lence factors such as the Panton-Valentine leukocidin are 
thought to contribute to the pathogen’s ability to cause 
skin and soft tissue infections.21 The underdeveloped epi-
dermis and frequent breeches in skin integrity due to in-
travenous catheters, blood draws and heel sticks place 
preterm neonates at risk of infection.22 With advances in 
our NICU, the survival rates, hospital stay and number of 
invasive procedures have increased. This might be part 
of the reason why S. aureus became the dominant Gram-
positive pathogen during the last decade.
Published data show that increased costs are associ-
ated with methicillin-resistant S. aureus (MRSA) compared 
with no infection or with methicillin-sensitive S. aureus.23 
Besides hand-hygiene, the isolation and cohorting of 
MRSA-colonized infants, and regular neonatal surveillance 
cultures were recommended.24 Many NICU are routinely 
using mupirocin to eradicate endemic MRSA. Lower erad-
ication rates have been observed in infants who are na-
sotracheally intubated or using nasal continuous positive 
airway pressure.22,25 The declining incidence of oxacillin-
resistant S. aureus seen in the current study might be re-
lated to changes in strict aseptic technique and hand 
washing policy (Figure 3), but the significance of this 
needs to be clarified.
CoNS is one of the most common healthcare-associated 
pathogens in NICUs. Levels of transplacental anti-CoNS 
immunoglobulin and complement correlate with gesta-
tional age, and this relative deficiency in preterm infants 
might contribute to their suboptimal opsonization and 
impaired bacterial killing of CoNS.26 In comparison with 
previous studies, CoNS is the predominant source of infec-
tion in NICU in the United States and Asian countries,27,28 
which is quite different from the community-acquired set-
ting. Gram-negative pathogens were responsible for most 
community-acquired neonatal infections and E. coli and 
Klebsiella species are the cause of nearly half of all infec-
tions in most regions of the world.29 A. baumannii, classi-
cally described as nosocomial pathogens in adults, is also 
responsible for infections in neonates hospitalized in ICUs, 
causing pneumonia. It is a ubiquitous microorganism im-
plicated in a number of outbreaks in ICUs.30 Most of these 
outbreaks have been traced to environmental sources, such 
as mechanical ventilation equipment and air conditioners.31 
Although no pan-drug resistant A. baumannii was isolated, 
two carbapenem-resistant strains appeared in recent years, 
and this trend should be closely monitored.
Candida infections are a common cause of late-onset 
sepsis in the NICU and are associated with significant 
mortality and neurodevelopmental impairment. Non-
albicans Candida spp. became more frequent after 2000; a 
similar trend was reported earlier in Taiwan.32 One of the 
most important developments in managing candidal in-
fection in the NICU is the use of prophylactic fluconazole 
in very-low-birthweight infants to prevent invasive candi-
diasis. The rationale for this strategy is to prevent fungal 
colonization in high-risk infants and reduce the invasiveness 
of the disease.33 Previous studies demonstrate a reduction 
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of disease invasiveness, but no difference in mortality.14,33 
The major concerns regarding fluconazole prophylaxis 
include the risk of selecting fluconazole resistant fungi, 
short- and long-term safety and cost.34 Whether the emer-
gence of non-albicans Candida resulted from the use of pro-
phylactic fluconazole is an important issue and demands 
further research.
In conclusion, bloodstream and skin/soft tissue in-
fections caused by commensal species play important 
roles in healthcare-associated infections in the NICU. An 
increased incidence of S. aureus and A. baumannii infection 
and a decreased number of CoNS infections were observed. 
Non-albicans Candida spp. also become more frequent dur-
ing 1999–2008. These changing patterns of isolated path-
ogens and antibiotic susceptibilities suggest that the use 
of empirical antibiotics for healthcare-associated infection 
in NICU needs constant review.
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